Biofrontera AG (B8F.DE)


XETRA - XETRA Delayed Price. Currency in EUR
3.18+0.02 (+0.63%)
At close: 11:36 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.17
Prev Close3.16
Bid0.00 x 84600
Ask0.00 x 20000
Day's Range3.08 - 3.18
52wk Range1.39 - 3.70
1y Target EstN/A
Market Cap96.63M
P/E Ratio (ttm)-8.02
BetaN/A
Volume20,717
Avg Vol (3m)31,938
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Biofrontera AG :B8F-DE: Earnings Analysis: 2015 By the Numbers
    Capital Cube4 months ago

    Biofrontera AG :B8F-DE: Earnings Analysis: 2015 By the Numbers

    Click here to see latest analysisBiofrontera AG reports financial results for the year ended December 31, 2015.We analyze the earnings along side the following peers of Biofrontera AG – WILEX AG (WL6-DE) that have also reported for this period.HighlightsGross margins widened from 37.86% to 50.71% compared to the same period last year, operating (EBITDA) margins […] (Read more...) The post Biofrontera AG :B8F-DE: Earnings Analysis: 2015 By the Numbers appeared first on CapitalCube.

  • GlobeNewswire5 months ago

    Biofrontera AG: Biofrontera Reports Full Year 2015 Financial Results

    Leverkusen, Germany, April 15, 2016 - Biofrontera AG (FSE: B8F), the specialist for sun-induced skin cancer, today reported its full year 2015 financial results for the year ended 31 December 2015.   - ...

  • GlobeNewswire5 months ago

    Biofrontera AG: Notice of Annual Results 2016

    Leverkusen, Germany, 07 April 2016 - Biofrontera AG (AIM: B8F), the specialist for sun-induced skin cancer, will be announcing its financial results for the twelve-month period ended 31 December 2015 on ...